Select Equity Group
WST icon

Select Equity Group’s West Pharmaceutical WST Stock Holding History

Select Equity Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-189,548
Closed -$44.6M – 197
2022
Q4 		$44.6M Buy
+189,548
New +$44.9M 0.17% 85
2020
Q2 		– Sell
-96,335
Closed -$14.7M – 169
2020
Q1 		$14.7M Buy
+96,335
New +$14.8M 0.1% 90
2018
Q3 		– Sell
-279,134
Closed -$27.7M – 104
2018
Q2 		$27.7M Sell
279,134
-1,616,782
-85% -$149M 0.22% 68
2018
Q1 		$167M Sell
1,895,916
-497,099
-21% -$46.5M 1.37% 25
2017
Q4 		$236M Sell
2,393,015
-1,046,079
-30% -$103M 1.88% 20
2017
Q3 		$331M Buy
3,439,094
+294,365
+9% +$26.6M 2.51% 13
2017
Q2 		$297M Buy
3,144,729
+221,379
+8% +$20.4M 2.12% 15
2017
Q1 		$239M Buy
2,923,350
+191,746
+7% +$16M 1.78% 19
2016
Q4 		$232M Buy
2,731,604
+316,704
+13% +$24.9M 1.9% 19
2016
Q3 		$180M Buy
2,414,900
+401,475
+20% +$31.9M 1.55% 23
2016
Q2 		$153M Buy
2,013,425
+100,998
+5% +$7.35M 1.34% 27
2016
Q1 		$133M Buy
1,912,427
+900,523
+89% +$54.2M 1.11% 30
2015
Q4 		$60.9M Buy
1,011,904
+429,066
+74% +$25.8M 0.58% 50
2015
Q3 		$31.5M Buy
+582,838
New +$34M 0.3% 65

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Select Equity Group's WST Position: Q1 2023 in Review

Select Equity Group sold out of West Pharmaceutical (WST) in Q1 2023, closing a stake of 189,548 shares — an estimated $44.6M sold.

Select Equity Group first reported a position in WST in Q3 2015 and held it in 14 quarters. The position peaked at $331M in Q3 2017. 695 funds tracked by Wall St. Rank hold WST as of Q1 2023.

  • Select Equity Group reported no remaining West Pharmaceutical position as of Q1 2023 after selling out during the quarter.
  • Select Equity Group sold 189,548 West Pharmaceutical shares in Q1 2023, an estimated $44.6M.
  • Select Equity Group first reported a position in West Pharmaceutical in Q3 2015 and held it in 14 quarters.
  • Select Equity Group's West Pharmaceutical position peaked at $331M in Q3 2017.
  • 695 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2023.

Based on Select Equity Group's 13F filing for Q1 2023, filed 15 May 2023.